Internet GHB Bust Could Lead To Future Web Shakedowns – DEA
This article was originally published in The Tan Sheet
Executive Summary
Leads and information obtained from a recent "takedown" of online gamma hydroxybutyrate (GHB) traffickers could result in future investigation and arrests, the Drug Enforcement Administration stated
You may also be interested in...
GHB Analog-Containing Product Demand High, NEJM Researchers Report
Extensive industrial use of the GHB analog 1,4-butanediol (BD), in conjunction with the flexibility and anonymity of Internet marketing, "ensures a continued supply that is almost impossible to regulate," researchers say in the Jan. 11 New England Journal of Medicine.
FDA Criminal Investigations Of Unapproved Drug Internet Sales Ongoing
FDA's Office of Criminal Investigations has 134 Internet-related investigations under way, 80 of which involve "various types of health fraud or other unapproved drug products" such as GHB. The other 54 cases involve Web sites selling prescription drugs.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC